Variants of the ban2401 Humanized Antibody that specifically binds to a protofibrillas with increased Serum half-life and uses in Pharmaceutical compositions for the treatment of Alzheimer's and other eNfermedades neurodegenerative (Divisional Application no. 53 - 2017).

摘要

The present Invention relates to beta Amyloid Peptide product (aΒ) and more specifically to protofibrillas Union aΒ Antibodies and their use in therapy and / or treatment of Disease PROFILÁCTICO 'Mer and other Disorders associated with Protein aggregation aΒ.The Invention can also refer to the diagnosis of such diseases as well as monitoring the Progress of the disease through the use of the Antibodies of the invention.In addition, The Invention can refer to the veterinary use of the Antibodies of the invention.